Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex.
Relocation of p25¿/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Diffusion tensor imaging in pediatric transverse myelitis: A case study.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Involvement and interplay of Parkin, PINK1 and DJ1 in neurodegenerative and neuroinflammatory disorders.
Multiple sclerosis: Interaction between IFN-β and vitamin D in modulation of MS risk.
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding.
The grey matter correlates of impaired decision-making in multiple sclerosis.
A facilitation and co-ordination therapy approach to the treatment of multiple sclerosis.
The role of iron in brain ageing and neurodegenerative disorders.
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
CD8(+) T cells in multiple sclerosis.
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
Pages
« first
‹ previous
…
231
232
233
234
235
236
237
238
239
…
next ›
last »